Related Practice Life Sciences & Pharma This report highlights how biopharma executives should adapt to the evolving biopharma landscape in both the nearer and longer term. 01262022160113
Article Digital AI Has Moved Beyond Hype — It Is Driving Performance and Deployment Is Widespread September 20, 2023
Executive Insights Life Sciences & Pharma Initial Drugs Selected for Medicare Price Negotiation: Emerging Perspectives September 1, 2023